You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API propafenone hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing propafenone hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline LLC RYTHMOL propafenone hydrochloride 0173-0823 FERRIC OXIDE RED
GlaxoSmithKline LLC RYTHMOL propafenone hydrochloride 0173-0823 GELATIN
GlaxoSmithKline LLC RYTHMOL propafenone hydrochloride 0173-0823 HYPROMELLOSE
GlaxoSmithKline LLC RYTHMOL propafenone hydrochloride 0173-0823 LECITHIN, SOYBEAN
GlaxoSmithKline LLC RYTHMOL propafenone hydrochloride 0173-0823 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing propafenone hydrochloride

Company Ingredient NDC Excipient
Actavis Pharma Inc propafenone hydrochloride 0591-0582 CELLULOSE, MICROCRYSTALLINE
Actavis Pharma Inc propafenone hydrochloride 0591-0582 CROSCARMELLOSE SODIUM
Actavis Pharma Inc propafenone hydrochloride 0591-0582 CROSPOVIDONE
Actavis Pharma Inc propafenone hydrochloride 0591-0582 HYPROMELLOSES
Actavis Pharma Inc propafenone hydrochloride 0591-0582 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for propafenone hydrochloride

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C YELLOW NO. 10

Excipient focus: ETHANOL

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE BLACK

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GELATIN TYPE A PORCINE

Excipient focus: GLYCERYL MONO AND DICAPRYLOCAPRATE

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

propafenone hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Par Pharmaceutical Inc propafenone hydrochloride 0603-5448
A-S Medication Solutions propafenone hydrochloride 50090-1134
Sun Pharmaceutical Industries Inc propafenone hydrochloride 53489-551
Physicians Total Care Inc propafenone hydrochloride 54868-4770
Aurobindo Pharma Limited propafenone hydrochloride 59651-256
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group